- Ekso Bionics looks to sell 10.5 million shares of its common stock, suggesting strategic moves by existing stakeholders.
- Analyst price targets for EKSO show significant upside potential, with estimates ranging widely between $1.00 and $9.00.
- GuruFocus estimates reveal a possible 240.72% gain based on the stock's estimated GF Value of $1.23.
Ekso Bionics Holdings Inc. (NASDAQ: EKSO) has recently filed to sell 10.5 million shares of its common stock, a significant development for investors monitoring the company's market movements. This move indicates an intended sale by existing shareholders, not a direct offer to sell.
Wall Street Analysts' Insights
According to analyses from two Wall Street analysts, Ekso Bionics Holdings Inc. (EKSO, Financial) presents a compelling investment opportunity, with an average price target set at $5.00. The projections show a high estimate of $9.00 and a low estimate of $1.00. This suggests a remarkable potential upside of 1,285.04% from the current trading price of $0.36. For more comprehensive details on these estimates, visit the Ekso Bionics Holdings Inc (EKSO) Forecast page.
The consensus from brokerage firms positions Ekso Bionics with an average recommendation score of 2.0, indicating an "Outperform" status. This rating is part of a five-point scale where 1 denotes a "Strong Buy" and 5 a "Sell."
Understanding GF Value Estimates
GuruFocus provides an estimated GF Value for Ekso Bionics Holdings Inc. (EKSO, Financial) at $1.23, forecasting a potential 240.72% increase from its current price of $0.36. The GF Value is an essential metric, reflecting the stock's fair trading value based on historical performance, previous trading multiples, and anticipated future business growth. For a deeper dive into the stock's potential, explore the detailed data available on the Ekso Bionics Holdings Inc (EKSO) Summary page.
